Evidence map›Paper›PMID 32108256›Full record

ArticleWorld journal of urology2020

Thulium-fiber laser for lithotripsy: first clinical experience in percutaneous nephrolithotomy.

Dmitry Enikeev, Mark Taratkin, Roman Klimov, Yuriy Alyaev, Leonid Rapoport, Magomed Gazimiev, Dmitry Korolev, Stanislav Ali, Gagik Akopyan, Dmitry Tsarichenko and 7 more

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in World journal of urology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04556201 (A Prospective, Multicenter, Post-Market Clinical Registry to Collect Real-World Evidence on the Clinical Performance of the SOLTIVE™ Laser for Treatment of Kidney or Ureteral Stones), which is not on this map. Cited by 37 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04556201 nacompletednot on this map

A Prospective, Multicenter, Post-Market Clinical Registry to Collect Real-World Evidence on the Clinical Performance of the SOLTIVE™ Laser for Treatment of Kidney or Ureteral Stones

TypeinterventionalSponsorOlympus Corporation of the AmericasRan2020 to 2023Enrolled450ConditionsKidney Stone, Ureteral StoneArmsSOLTIVE™ Premium SuperPulsed Laser Fiber System
3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Adoption of thulium fiber laser for lithotripsy A scoping review and bibliometric analysis.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Observational
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Dmitry EnikeevInstitute for Urology and Reproductive Health, Sechenov University, 2/1 Bolshaya Pirogovskaya St., Moscow, 119991, Russian Federation. dvenikeev@gmail.com.ORCID http://orcid.org/0000-0001-7169-2209
Mark TaratkinInstitute for Urology and Reproductive Health, Sechenov University, 2/1 Bolshaya Pirogovskaya St., Moscow, 119991, Russian Federation.
Roman KlimovInstitute for Urology and Reproductive Health, Sechenov University, 2/1 Bolshaya Pirogovskaya St., Moscow, 119991, Russian Federation.
Yuriy AlyaevInstitute for Urology and Reproductive Health, Sechenov University, 2/1 Bolshaya Pirogovskaya St., Moscow, 119991, Russian Federation.
Leonid RapoportInstitute for Urology and Reproductive Health, Sechenov University, 2/1 Bolshaya Pirogovskaya St., Moscow, 119991, Russian Federation.
Magomed GazimievInstitute for Urology and Reproductive Health, Sechenov University, 2/1 Bolshaya Pirogovskaya St., Moscow, 119991, Russian Federation.
Dmitry KorolevInstitute for Urology and Reproductive Health, Sechenov University, 2/1 Bolshaya Pirogovskaya St., Moscow, 119991, Russian Federation.
Stanislav AliInstitute for Urology and Reproductive Health, Sechenov University, 2/1 Bolshaya Pirogovskaya St., Moscow, 119991, Russian Federation.
Gagik AkopyanInstitute for Urology and Reproductive Health, Sechenov University, 2/1 Bolshaya Pirogovskaya St., Moscow, 119991, Russian Federation.
Dmitry TsarichenkoInstitute for Urology and Reproductive Health, Sechenov University, 2/1 Bolshaya Pirogovskaya St., Moscow, 119991, Russian Federation.
Irina MarkovinaInstitute of Linguistics and Intercultural Communication, Sechenov University, Moscow, Russia.
Eugenio VentimigliaGRC #20 Lithiase Urinaire, Hôpital Tenon, Sorbonne University, Paris, France.
Evgenia GoryachevaDepartment of Internal Diseases, Sechenov University, Moscow, Russia.
Zhamshid OkhunovDepartment of Urology, University of California, Irvine, USA.
Francis A JeffersonInstitute of Linguistics and Intercultural Communication, Sechenov University, Moscow, Russia.
Petr GlybochkoInstitute for Urology and Reproductive Health, Sechenov University, 2/1 Bolshaya Pirogovskaya St., Moscow, 119991, Russian Federation.
Olivier TraxerGRC #20 Lithiase Urinaire, Hôpital Tenon, Sorbonne University, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo evaluate the efficacy and safety of thulium-fiber laser (TFL) in laser lithotripsy during percutaneous nephrolithotomy (PCNL).

methodsPatients with stones < 30 mm were prospectively recruited to undergo PCNL using TFL "FiberLase" (NTO IRE-Polus, Russia). Stone size, stone density, operative time, and "laser on" time (LOT) were recorded. Study included only cases managed with fragmentation. Stone-free rate and residual fragments were determined on postoperative computer tomography. Complications were classified using the Clavien-Dindo grade. Stone retropulsion and endoscopic visibility were assessed based on surgeons' feedback using a questionnaire.

resultsA total of 120 patients were included in the study with a mean age of 52 (± 1.8) years; of these 77 (56%) were males. Mean stone size was 12.5 (± 8.8) mm with a mean density of 1019 (± 375) HU. Mean operative time was 23.4 (± 17.9) min and mean LOT was 5.0 (± 5.7) min. Most used settings were of 0.8 J/25-30 W/31-38 Hz (fragmentation). The mean total energy for stone ablation was 3.6 (± 4.3) kJ. Overall stone-free rate was 85%. The overall complication rate was 17%. Surgeons reported stone retropulsion that interfered with surgery in 2 (1.7%) cases insignificant retropulsion was noted in 16 (10.8%) cases. Poor visualization was reported in three (2.5%) cases and minor difficulties with visibility in four (3.3%) cases.

conclusionsTFL is a safe and effective modality for lithotripsy during PCNL and results in minimal retropulsion.

Indexed as

Nephrolithotomy, PercutaneousThuliumAdolescentAdultAgedAged, 80 and overCombined Modality TherapyFemaleHumansKidney CalculiLithotripsy, LaserMaleMiddle AgedProspective StudiesTreatment OutcomeYoung AdultThuliumKidneyPercutaneous nephrolithotripsyThulium-fiber laserUreterUrinary stonesUrolithiasis

Identifiers

PMID32108256

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.